10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 642,823 | 610,785 | 618,727 | 516,409 | 490,490 |
| Cost of Goods | 198,942 | 196,303 | 209,414 | 120,386 | 74,091 |
| Gross Profit | 443,881 | 414,482 | 409,313 | 396,023 | 416,399 |
| Operating Expenses | 505,808 | 609,344 | 675,056 | 564,353 | 468,743 |
| Operating Income | -60,985 | -194,559 | -265,329 | -167,944 | -52,253 |
| Interest Expense | 0 | 4 | 33 | 476 | 866 |
| Other Income | 21,078 | 16,863 | 16,599 | 6,449 | -596 |
| Pre-tax Income | -39,907 | -177,700 | -248,763 | -161,971 | -53,715 |
| Income Tax | 3,637 | 4,927 | 6,336 | 4,029 | 4,508 |
| Net Income Continuous | -43,544 | -182,627 | -255,099 | -166,000 | -58,223 |
| Net Income | $-43,544 | $-182,627 | $-255,099 | $-166,000 | $-58,223 |
| EPS Basic Total Ops | -0.35 | -1.52 | -2.18 | -1.46 | -0.53 |
| EPS Basic Continuous Ops | -0.35 | -1.52 | -2.18 | -1.46 | -0.53 |
| EPS Diluted Total Ops | -0.35 | -1.52 | -2.18 | -1.46 | -0.53 |
| EPS Diluted Continuous Ops | -0.35 | -1.52 | -2.18 | -1.46 | -0.53 |
| EPS Diluted Before Non-Recurring Items | -0.43 | -1.52 | -1.66 | -1.46 | -0.53 |
| EBITDA(a) | $-17,169 | $-150,851 | $-221,710 | $-134,938 | $-23,999 |